# FDA Inspection 971681 - Louise Taber, MD - May 20, 2016

Source: https://www.keypedia.com/records/fda_inspections/louise-taber-md/21e0f686-e866-469d-8b70-a7ea59aafcf9
Source feed: FDA_Inspections

> FDA Inspection 971681 for Louise Taber, MD on May 20, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 971681
- Company Name: Louise Taber, MD
- Inspection Date: 2016-05-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1251100 - 2024-09-26](https://www.keypedia.com/records/fda_inspections/louise-taber-md/690aa0c6-4617-4a0b-9b02-9a38e648dc0b)
- [FDA Inspection 1251100 - 2024-09-26](https://www.keypedia.com/records/fda_inspections/louise-taber-md/9fbd4936-d750-4681-be88-ada5340ded72)
- [FDA Inspection 888259 - 2014-07-18](https://www.keypedia.com/records/fda_inspections/louise-taber-md/9c1b4936-be59-4932-9b01-2f136eedb92f)

Company: https://www.keypedia.com/companies/louise-taber-md/fb11ea8d-56e5-4a35-8ba4-b462b4ccf4c1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c